The clinical challenge of cardiorenal syndrome

被引：179
作者：
Shlipak, MG
Massie, BM
机构：
[1] Vet Affairs Med Ctr, Cardiol Div 111C, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[5] San Francisco VA Med Ctr, Gen Internal Med Sect, San Francisco, CA USA
来源：
CIRCULATION | 2004年 / 110卷 / 12期
关键词：
heart failure; kidney; natriuretic peptides; vasodilation;
D O I：
10.1161/01.CIR.0000143547.55093.17
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1514 / 1517
页数：4
相关论文
共 26 条
[1]  
Abraham W T, 1998, J Card Fail, V4, P37, DOI 10.1016/S1071-9164(98)90506-1
[2]   Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern? [J].
Bakris, GL ;
Weir, MR .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (05) :685-693
[3]   Relationship between heart failure treatment and development of worsening renal function among hospitalized patients [J].
Butler, J ;
Forman, DE ;
Abraham, WT ;
Gottlieb, SS ;
Loh, E ;
Massie, BM ;
O'Connor, CM ;
Rich, MW ;
Stevenson, LW ;
Wang, YF ;
Young, JB ;
Krumholz, HM .
AMERICAN HEART JOURNAL, 2004, 147 (02) :331-338
[4]   The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure [J].
Butler, J ;
Emerman, C ;
Peacock, WF ;
Mathur, VS ;
Young, JB .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (02) :391-399
[5]   Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. [J].
Colucci, WS ;
Elkayam, U ;
Horton, DP ;
Abraham, WT ;
Bourge, RC ;
Johnson, AD ;
Wagoner, LE ;
Givertz, MM ;
Liang, CS ;
Neibaur, M ;
Haught, WH .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) :246-253
[6]   The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction [J].
Dries, DL ;
Exner, DV ;
Domanski, MJ ;
Greenberg, B ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :681-689
[7]   Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction:: The EPICAL study [J].
Echemann, M ;
Zannad, F ;
Briançon, S ;
Juillière, Y ;
Mertès, PM ;
Virion, JM ;
Villemot, JP .
AMERICAN HEART JOURNAL, 2000, 139 (04) :624-631
[8]   Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure [J].
Forman, DE ;
Butler, J ;
Wang, YF ;
Abraham, WT ;
O'Connor, CM ;
Gottlieb, SS ;
Loh, E ;
Massie, BM ;
Rich, MW ;
Stevenson, LW ;
Young, JB ;
Krumholz, HM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (01) :61-67
[9]   Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure - A randomized controlled trial [J].
Gheorghiade, M ;
Gattis, WA ;
O'Connor, CM ;
Adams, KF ;
Elkayam, U ;
Barbagelata, A ;
Ghali, JK ;
Benza, RL ;
McGrew, FA ;
Klapholz, M ;
Ouyang, J ;
Orlandi, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (16) :1963-1971
[10]   The prognostic importance of different definitions of worsening renal function in congestive heart failure [J].
Gottlieb, SS ;
Abraham, W ;
Butler, J ;
Forman, DE ;
Loh, E ;
Massie, BM ;
O'Connor, CM ;
Rich, MW ;
Stevenson, LW ;
Young, J ;
Krumholz, HM .
JOURNAL OF CARDIAC FAILURE, 2002, 8 (03) :136-141
123